XML 39 R26.htm IDEA: XBRL DOCUMENT v3.20.4
Summary of Significant Accounting Policies (Tables)
12 Months Ended
Dec. 31, 2020
Schedule of Cash, Cash Equivalents and Restricted Cash
The following is a summary of the Company’s cash, cash equivalents, and restricted cash total as presented in the Company’s consolidated statements of cash flows for the years ended December 31, 2020, 2019 and 2018:
 
    
For the Years Ended December 31,
 
    
2020
    
2019
    
2018
 
    
(Amounts in thousands)
 
Cash and cash equivalents
   $ 717,292      $ 528,392      $ 193,822  
Restricted cash
     —          9,015        —    
    
 
 
    
 
 
    
 
 
 
Total cash, cash equivalents, and restricted cash
   $ 717,292      $ 537,407      $ 193,822  
    
 
 
    
 
 
    
 
 
 
Property, Plant and Equipment
Property, plant & equipment is recorded at cost less allowances for depreciation. Depreciation is calculated using the straight-line method over the estimated useful life of the asset as follows:
 
Classification
  
Estimated Useful Life
Buildings
   Thirty years
Leasehold improvements
   Shorter of the term of the lease or estimated useful life
Equipment
   Three to twelve years
Furniture, fixtures and office equipment
   Three to eight years
Computer hardware and software
   Three to seven years or estimated useful life
Reconciliation of Basic and Diluted Shares Amounts
A reconciliation of basic and diluted share amounts is as follows:
 
   
For the Years Ended
December 31,
 
   
    2020    
   
    2019    
   
    2018    
 
   
(Amounts in thousands, except
per share data)
 
Net income
  $ 59,926     $ 21,411     $ 16,617  
   
 
 
   
 
 
   
 
 
 
Weighted average shares used in computing net income per share - basic
    52,554       48,343       43,767  
Effect of dilutive shares:
                       
Options and stock units
    971       864       581  
Convertible senior notes
    367       —         1,123  
   
 
 
   
 
 
   
 
 
 
Dilutive potential common shares
    1,338       864       1,704  
   
 
 
   
 
 
   
 
 
 
Weighted average shares used in computing net income per share - diluted
    53,892       49,206       45,471  
   
 
 
   
 
 
   
 
 
 
Earnings per share:
                       
Basic
  $ 1.14     $ 0.44     $ 0.38  
   
 
 
   
 
 
   
 
 
 
Diluted
  $ 1.11     $ 0.44     $ 0.37  
   
 
 
   
 
 
   
 
 
 
Summary of Product Revenues by Product Line
The following table represents product revenues by product line:
 
    
For the Years Ended December 31,
 
    
2020
(1)
    
2019
(2)
    
2018
 
    
(Amounts in thousands)
 
Filtration products
   $ 174,896      $ 119,534      $ 90,586  
Chromatography products
     73,551        64,635        45,326  
Process analytics products
     33,346        16,405        —    
Proteins products
     80,732        65,124        54,375  
Other
     3,611        4,399        3,604  
    
 
 
    
 
 
    
 
 
 
Total product revenue
   $ 366,136      $ 270,097      $ 193,891  
    
 
 
    
 
 
    
 
 
 
 
(1)
2020 revenue for filtration products includes revenue related to EMT from July 13, 2020, NMS from October 20, 2020 and ARTeSYN from December 3, 2020.
(2)
2019 revenue for process analytics products includes revenue related to C Technologies from May 31, 2019 through December 31, 2019.
Total Assets by Geographic Area
The following table represents the Company’s total assets by geographic area:
 
    
December 31,
 
    
2020
    
2019
 
    
(Amounts in thousands)
 
Total assets by geographic locations:
                 
North America
   $ 1,697,149      $ 1,260,217  
Europe
     188,698        133,599  
APAC
     17,040        6,297  
    
 
 
    
 
 
 
Total assets by geographic location
   $ 1,902,887      $ 1,400,113  
    
 
 
    
 
 
 
Long Lived Assets by Geographic Area
The following table represents the Company’s long-lived assets by geographic area:
 
    
December 31,
 
    
2020
    
2019
 
    
(Amounts in
thousands)
 
Long-lived assets by geographic locations:
                 
North America
   $ 78,429      $ 66,756  
Europe
     12,918        6,775  
APAC
     1,272        869  
    
 
 
    
 
 
 
Total long-lived assets by geographic location
   $ 92,619      $ 74,400  
    
 
 
    
 
 
 
Percentage of Revenue from Significant Customers
Revenue from significant customers that represent 10% or more of the Company’s total revenue is as follows:
 
    
For the Years Ended
December 31,
 
    
    2020    
   
    2019    
   
    2018    
 
MilliporeSigma
     11     13     15
Cytiva (formerly GE Healthcare)
     N/A       12     15
Total Revenue  
Percentage by Geographic Area or Significant Customers
The following table represents the Company’s total revenue by geographic area (based on the location of the customer):
 
    
For the Years Ended
December 31,
 
    
    2020    
   
    2019    
   
    2018    
 
Revenue by customers’ geographic locations:
                        
North America
     48     51     48
Europe
     38     37     40
APAC/Other
     14     12     12
    
 
 
   
 
 
   
 
 
 
Total revenue
     100     100     100